CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
7,497,694
Share change
-243,542
Total reported value
$60,599,755
Price per share
$8.09
Number of holders
33
Value change
-$3,749,413
Number of buys
24
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q3 2015

As of 30 Sep 2015, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,497,694 shares. The largest 10 holders included Clarus Ventures, LLC, FMR LLC, Camber Capital Management LLC, DEERFIELD MANAGEMENT CO, SPHERA FUNDS MANAGEMENT LTD., WELLINGTON MANAGEMENT GROUP LLP, Rhenman & Partners Asset Management AB, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, and BlackRock Fund Advisors. This page lists 33 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.